U.S. markets closed

Veracyte, Inc. (VCYT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
50.61+1.44 (+2.93%)
At close: 4:00PM EDT
50.61 0.00 (0.00%)
After hours: 04:55PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close49.17
Open49.59
Bid48.93 x 800
Ask50.61 x 800
Day's Range49.23 - 50.95
52 Week Range28.82 - 86.03
Volume267,682
Avg. Volume673,595
Market Cap3.586B
Beta (5Y Monthly)0.77
PE Ratio (TTM)N/A
EPS (TTM)-1.04
Earnings DateNov 01, 2021 - Nov 05, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est63.17
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Veracyte, Inc.
    Analyst Report: Myriad Genetics, Inc.Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual’s risk of developing a disease. The firm produces myRisk, a 35-gene panel with the capability to identify the elevated risk of developing eight types of cancer. Other diagnostic products include BRACAnalysisCDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; Vectra DA, which predicts disease progression in rheumatoid arthritis to optimize drug treatment; and Prolaris, which identifies prostate cancer patients that can pursue active surveillance. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.
    Rating
    Fair Value
    Economic Moat
    22 hours agoMorningstar
View more